Cardiosense
AI-powered Cardiac Monitoring
5 open rolesAI-powered Cardiac MonitoringChicago, United States9 employees$18M raisedEst. 2020
About Cardiosense
- Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.
- Their flagship product, CardioTag, is a wearable cardiac sensor that has received FDA 510(k) clearance and Breakthrough Device Designation.
Cardiosense is listed on Rocketlist with 5 active roles. The company is categorized as AI-powered Cardiac Monitoring in MedTech. Cardiosense is at Series A stage, with a B2B business model, headquartered in Chicago, United States. Cardiosense was founded in 2020 and has 9 employees. Cardiosense has raised $18M. Active roles are refreshed daily from public hiring sources.